Definition of Sifalimumab. Meaning of Sifalimumab. Synonyms of Sifalimumab

Here you will find one or more explanations in English for the word Sifalimumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Sifalimumab and, of course, Sifalimumab synonyms and on the right images related to the word Sifalimumab.

Definition of Sifalimumab

No result for Sifalimumab. Showing similar results...

Meaning of Sifalimumab from wikipedia

- Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- MedImmune, a unit of AstraZeneca, which chose to move anifrolumab instead of sifalimumab into phase III trials for lupus in 2015. On 16 December 2021, the Committee...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- sibrafiban (INN) sibrotuzumab (INN) sibutramine (INN) siccanin (INN) Sidapvia sifalimumab (USAN, INN) sifaprazine (INN) sifilcon A (USAN) siguazodan (INN) Siiltibcy...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...
- Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ)...